Concepedia

Mark A. Dawson

MA

86

Publications

11.4K

Citations

47

H-Index

1976

Active since

Affiliations

Peter MacCallum Cancer Centre(Current)

The University of Melbourne

Walter and Eliza Hall Institute of Medical Research

University of Cambridge

Monash University

Mark A. Dawson is an author at Peter MacCallum Cancer Centre specializing in medicine, cell biology, and chromatin.

Top concepts

MedicineCell BiologyChromatinTumor BiologyCancer ResearchHematologyImmunologyEpigeneticsCell SignalingHealth

Publications per year

1976–2025

86

Publications

86

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

Mark A. Dawson, Rab K. Prinjha, Antje Dittmann et al. · Nature · 2011 · 1.5K citations · Full text

Hematological Malignancy, Chromatin, Bet Recruitment +11

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

Marian L. Burr, Christina E. Sparbier, Yih-Chih Chan et al. · Nature · 2017 · 910 citations · Full text

Cancer Immunosurveillance, Medicine, Immunology +8

JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin

Mark A. Dawson, Andrew J. Bannister, Berthold Göttgens et al. · Nature · 2009 · 600 citations

Histone Modifications, Chromatin, Transcriptional Regulation +12

An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer

Marian L. Burr, Christina E. Sparbier, Kah Lok Chan et al. · Cancer Cell · 2019 · 596 citations · Full text

BET inhibitor resistance emerges from leukaemia stem cells

Chun Yew Fong, Omer Gilan, Enid Y.N. Lam et al. · Nature · 2015 · 542 citations · Full text

Hematological Malignancy, Cell Therapy, Bet Inhibitor Resistance +5

Rows per page

1–5 of 86